Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 86 entries
Sorted by: Best Match Show Resources per page
Hodgkin's disease and cellular immune mechanisms.

Pediatrics

Phillips KM, Marinkovich VA.
PMID: 5542796
Pediatrics. 1971 Feb;47(2):478-80.

No abstract available.

Cite
Phillips KM, Marinkovich VA. Hodgkin's disease and cellular immune mechanisms. Pediatrics. 1971;47(2):478-80
Phillips, K. M., & Marinkovich, V. A. (1971). Hodgkin's disease and cellular immune mechanisms. Pediatrics, 47(2), 478-80.
Phillips, K M, and Marinkovich, V A. "Hodgkin's disease and cellular immune mechanisms." Pediatrics vol. 47,2 (1971): 478-80.
Phillips KM, Marinkovich VA. Hodgkin's disease and cellular immune mechanisms. Pediatrics. 1971 Feb;47(2):478-80. PMID: 5542796.
Copy Download .nbib Format: NLM
Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines.

Cancers

Chau C, van Doorn R, van Poppelen NM, van der Stoep N, Mensenkamp AR, Sijmons RH, van Paassen BW, van den Ouweland AMW, Naus NC, van der Hout AH, Potjer TP, Bleeker FE, Wevers MR, van Hest LP, Jongmans MCJ, Marinkovic M, Bleeker JC, Jager MJ, Luyten GPM, Nielsen M.
PMID: 31382694
Cancers (Basel). 2019 Aug 04;11(8). doi: 10.3390/cancers11081114.

Germline pathogenic variants in the BRCA1-associated protein-1 (

Cite
Chau C, van Doorn R, van Poppelen NM, et al. Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. Cancers (Basel). 2019;11(8)doi: 10.3390/cancers11081114.
Chau, C., van Doorn, R., van Poppelen, N. M., van der Stoep, N., Mensenkamp, A. R., Sijmons, R. H., van Paassen, B. W., van den Ouweland, A. M. W., Naus, N. C., van der Hout, A. H., Potjer, T. P., Bleeker, F. E., Wevers, M. R., van Hest, L. P., Jongmans, M. C. J., Marinkovic, M., Bleeker, J. C., Jager, M. J., Luyten, G. P. M., & Nielsen, M. (2019). Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. Cancers, 11(8), . https://doi.org/10.3390/cancers11081114
Chau, Cindy, et al. "Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines." Cancers vol. 11,8 (2019). doi: https://doi.org/10.3390/cancers11081114
Chau C, van Doorn R, van Poppelen NM, van der Stoep N, Mensenkamp AR, Sijmons RH, van Paassen BW, van den Ouweland AMW, Naus NC, van der Hout AH, Potjer TP, Bleeker FE, Wevers MR, van Hest LP, Jongmans MCJ, Marinkovic M, Bleeker JC, Jager MJ, Luyten GPM, Nielsen M. Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. Cancers (Basel). 2019 Aug 04;11(8). doi: 10.3390/cancers11081114. PMID: 31382694; PMCID: PMC6721807.
Copy Download .nbib Format: NLM
MRI of Uveal Melanoma.

Cancers

Ferreira TA, Grech Fonk L, Jaarsma-Coes MG, van Haren GGR, Marinkovic M, Beenakker JM.
PMID: 30884881
Cancers (Basel). 2019 Mar 17;11(3). doi: 10.3390/cancers11030377.

Uveal Melanoma (UM) is the most common primary malignant ocular tumor. The high soft tissue contrast and spatial resolution, and the possibility of generating 3D volumetric and functional images, make Magnetic Resonance Imaging (MRI) a valuable diagnostic imaging technique...

Cite
Ferreira TA, Grech Fonk L, Jaarsma-Coes MG, et al. MRI of Uveal Melanoma. Cancers (Basel). 2019;11(3)doi: 10.3390/cancers11030377.
Ferreira, T. A., Grech Fonk, L., Jaarsma-Coes, M. G., van Haren, G. G. R., Marinkovic, M., & Beenakker, J. M. (2019). MRI of Uveal Melanoma. Cancers, 11(3), . https://doi.org/10.3390/cancers11030377
Ferreira, Teresa A, et al. "MRI of Uveal Melanoma." Cancers vol. 11,3 (2019). doi: https://doi.org/10.3390/cancers11030377
Ferreira TA, Grech Fonk L, Jaarsma-Coes MG, van Haren GGR, Marinkovic M, Beenakker JM. MRI of Uveal Melanoma. Cancers (Basel). 2019 Mar 17;11(3). doi: 10.3390/cancers11030377. PMID: 30884881; PMCID: PMC6468484.
Copy Download .nbib Format: NLM
Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative .

EFSA journal. European Food Safety Authority

, Hernandez-Jerez AF, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S, Focks A, Marinovich M, Millet M, Pelkonen O, Pieper S, Tiktak A, Topping CJ, Widenfalk A, Wilks M, Wolterink G, Gundert-Remy U, Louisse J, Rudaz S, Testai E, Lostia A, Dorne JL, Parra Morte JM.
PMID: 34987623
EFSA J. 2021 Dec 23;19(12):e06970. doi: 10.2903/j.efsa.2021.6970. eCollection 2021 Dec.

EFSA asked the Panel on Plant Protection Products and their residues to deliver a Scientific Opinion on testing and interpretation of comparative

Cite
, Hernandez-Jerez AF, Adriaanse P, et al. Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative . EFSA J. 2021;19(12):e06970doi: 10.2903/j.efsa.2021.6970.
, Hernandez-Jerez, A. F., Adriaanse, P., Aldrich, A., Berny, P., Coja, T., Duquesne, S., Focks, A., Marinovich, M., Millet, M., Pelkonen, O., Pieper, S., Tiktak, A., Topping, C. J., Widenfalk, A., Wilks, M., Wolterink, G., Gundert-Remy, U., Louisse, J., Rudaz, S., Testai, E., Lostia, A., Dorne, J. L., & Parra Morte, J. M. (2021). Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative . EFSA journal. European Food Safety Authority, 19(12), e06970. https://doi.org/10.2903/j.efsa.2021.6970
, et al. "Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative ." EFSA journal. European Food Safety Authority vol. 19,12 (2021): e06970. doi: https://doi.org/10.2903/j.efsa.2021.6970
, Hernandez-Jerez AF, Adriaanse P, Aldrich A, Berny P, Coja T, Duquesne S, Focks A, Marinovich M, Millet M, Pelkonen O, Pieper S, Tiktak A, Topping CJ, Widenfalk A, Wilks M, Wolterink G, Gundert-Remy U, Louisse J, Rudaz S, Testai E, Lostia A, Dorne JL, Parra Morte JM. Scientific Opinion of the Scientific Panel on Plant Protection Products and their Residues (PPR Panel) on testing and interpretation of comparative . EFSA J. 2021 Dec 23;19(12):e06970. doi: 10.2903/j.efsa.2021.6970. eCollection 2021 Dec. PMID: 34987623; PMCID: PMC8696562.
Copy Download .nbib Format: NLM
Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history study.

Journal of the American Academy of Dermatology

Solis DC, Teng C, Gorell ES, Barriga M, Nazaroff J, Li S, Lu Y, Bruckner A, Marinkovich MP, Tang JY.
PMID: 32896597
J Am Acad Dermatol. 2021 Nov;85(5):1296-1298. doi: 10.1016/j.jaad.2020.08.118. Epub 2020 Sep 04.

No abstract available.

Cite
Solis DC, Teng C, Gorell ES, et al. Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history study. J Am Acad Dermatol. 2020;85(5):1296-1298doi: 10.1016/j.jaad.2020.08.118.
Solis, D. C., Teng, C., Gorell, E. S., Barriga, M., Nazaroff, J., Li, S., Lu, Y., Bruckner, A., Marinkovich, M. P., & Tang, J. Y. (2021). Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history study. Journal of the American Academy of Dermatology, 85(5), 1296-1298. https://doi.org/10.1016/j.jaad.2020.08.118
Solis, Daniel C, et al. "Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history study." Journal of the American Academy of Dermatology vol. 85,5 (2021): 1296-1298. doi: https://doi.org/10.1016/j.jaad.2020.08.118
Solis DC, Teng C, Gorell ES, Barriga M, Nazaroff J, Li S, Lu Y, Bruckner A, Marinkovich MP, Tang JY. Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history study. J Am Acad Dermatol. 2021 Nov;85(5):1296-1298. doi: 10.1016/j.jaad.2020.08.118. Epub 2020 Sep 04. PMID: 32896597.
Copy Download .nbib Format: NLM
MR and CT Imaging of the Normal Eyelid and its Application in Eyelid Tumors.

Cancers

Ferreira TA, Pinheiro CF, Saraiva P, Jaarsma-Coes MG, Van Duinen SG, Genders SW, Marinkovic M, Beenakker JM.
PMID: 32178233
Cancers (Basel). 2020 Mar 12;12(3). doi: 10.3390/cancers12030658.

T-staging of most eyelid malignancies includes the assessment of the integrity of the tarsal plate and orbital septum, which are not clinically accessible. Given the contribution of MRI in the characterization of orbital tumors and establishing their relations to...

Cite
Ferreira TA, Pinheiro CF, Saraiva P, et al. MR and CT Imaging of the Normal Eyelid and its Application in Eyelid Tumors. Cancers (Basel). 2020;12(3)doi: 10.3390/cancers12030658.
Ferreira, T. A., Pinheiro, C. F., Saraiva, P., Jaarsma-Coes, M. G., Van Duinen, S. G., Genders, S. W., Marinkovic, M., & Beenakker, J. M. (2020). MR and CT Imaging of the Normal Eyelid and its Application in Eyelid Tumors. Cancers, 12(3), . https://doi.org/10.3390/cancers12030658
Ferreira, Teresa A, et al. "MR and CT Imaging of the Normal Eyelid and its Application in Eyelid Tumors." Cancers vol. 12,3 (2020). doi: https://doi.org/10.3390/cancers12030658
Ferreira TA, Pinheiro CF, Saraiva P, Jaarsma-Coes MG, Van Duinen SG, Genders SW, Marinkovic M, Beenakker JM. MR and CT Imaging of the Normal Eyelid and its Application in Eyelid Tumors. Cancers (Basel). 2020 Mar 12;12(3). doi: 10.3390/cancers12030658. PMID: 32178233; PMCID: PMC7139934.
Copy Download .nbib Format: NLM
Radiation Damage Mechanisms of Chemotherapeutically Active Nitroimidazole Derived Compounds.

Frontiers in chemistry

Chiarinelli J, Casavola AR, Castrovilli MC, Bolognesi P, Cartoni A, Wang F, Richter R, Catone D, Tosic S, Marinkovic BP, Avaldi L.
PMID: 31157205
Front Chem. 2019 May 14;7:329. doi: 10.3389/fchem.2019.00329. eCollection 2019.

Photoionization mass spectrometry, photoelectron-photoion coincidence spectroscopic technique, and computational methods have been combined to investigate the fragmentation of two nitroimidazole derived compounds: the metronidazole and misonidazole. These molecules are used in radiotherapy thanks to their capability to sensitize hypoxic...

Cite
Chiarinelli J, Casavola AR, Castrovilli MC, et al. Radiation Damage Mechanisms of Chemotherapeutically Active Nitroimidazole Derived Compounds. Front Chem. 2019;7:329doi: 10.3389/fchem.2019.00329.
Chiarinelli, J., Casavola, A. R., Castrovilli, M. C., Bolognesi, P., Cartoni, A., Wang, F., Richter, R., Catone, D., Tosic, S., Marinkovic, B. P., & Avaldi, L. (2019). Radiation Damage Mechanisms of Chemotherapeutically Active Nitroimidazole Derived Compounds. Frontiers in chemistry, 7329. https://doi.org/10.3389/fchem.2019.00329
Chiarinelli, Jacopo, et al. "Radiation Damage Mechanisms of Chemotherapeutically Active Nitroimidazole Derived Compounds." Frontiers in chemistry vol. 7 (2019): 329. doi: https://doi.org/10.3389/fchem.2019.00329
Chiarinelli J, Casavola AR, Castrovilli MC, Bolognesi P, Cartoni A, Wang F, Richter R, Catone D, Tosic S, Marinkovic BP, Avaldi L. Radiation Damage Mechanisms of Chemotherapeutically Active Nitroimidazole Derived Compounds. Front Chem. 2019 May 14;7:329. doi: 10.3389/fchem.2019.00329. eCollection 2019. PMID: 31157205; PMCID: PMC6528692.
Copy Download .nbib Format: NLM
Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma.

JAMA ophthalmology

Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, Brouwer NJ, Marinkovic M, Van Duinen SG, Caujolle JP, Maschi C, Seregard S, Pelayes D, Folgar M, Yousef YA, Krema H, Gallie B, Calle-Vasquez A.
PMID: 31169891
JAMA Ophthalmol. 2019 Aug 01;137(8):905-911. doi: 10.1001/jamaophthalmol.2019.1640.

IMPORTANCE: Eye cancer staging systems used for standardizing patient care and research need to be validated.OBJECTIVE: To evaluate the accuracy of the eighth edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual in estimating metastatis and...

Cite
Jain P, Finger PT, Damato B, et al. Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma. JAMA Ophthalmol. 2019;137(8):905-911doi: 10.1001/jamaophthalmol.2019.1640.
Jain, P., Finger, P. T., Damato, B., Coupland, S. E., Heimann, H., Kenawy, N., Brouwer, N. J., Marinkovic, M., Van Duinen, S. G., Caujolle, J. P., Maschi, C., Seregard, S., Pelayes, D., Folgar, M., Yousef, Y. A., Krema, H., Gallie, B., Calle-Vasquez, A. (2019). Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma. JAMA ophthalmology, 137(8), 905-911. https://doi.org/10.1001/jamaophthalmol.2019.1640
Jain, Puneet, et al. "Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma." JAMA ophthalmology vol. 137,8 (2019): 905-911. doi: https://doi.org/10.1001/jamaophthalmol.2019.1640
Jain P, Finger PT, Damato B, Coupland SE, Heimann H, Kenawy N, Brouwer NJ, Marinkovic M, Van Duinen SG, Caujolle JP, Maschi C, Seregard S, Pelayes D, Folgar M, Yousef YA, Krema H, Gallie B, Calle-Vasquez A. Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma. JAMA Ophthalmol. 2019 Aug 01;137(8):905-911. doi: 10.1001/jamaophthalmol.2019.1640. PMID: 31169891; PMCID: PMC6555476.
Copy Download .nbib Format: NLM
Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options.

Progress in retinal and eye research

Brouwer NJ, Verdijk RM, Heegaard S, Marinkovic M, Esmaeli B, Jager MJ.
PMID: 34015548
Prog Retin Eye Res. 2021 May 17;100971. doi: 10.1016/j.preteyeres.2021.100971. Epub 2021 May 17.

Recent developments in oncology have led to a better molecular and cellular understanding of cancer, and the introduction of novel therapies. Conjunctival melanoma (CoM) is a rare but potentially devastating disease. A better understanding of CoM, leading to the...

Cite
Brouwer NJ, Verdijk RM, Heegaard S, et al. Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options. Prog Retin Eye Res. 2021;100971doi: 10.1016/j.preteyeres.2021.100971.
Brouwer, N. J., Verdijk, R. M., Heegaard, S., Marinkovic, M., Esmaeli, B., & Jager, M. J. (2021). Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options. Progress in retinal and eye research, 100971. https://doi.org/10.1016/j.preteyeres.2021.100971
Brouwer, Niels J, et al. "Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options." Progress in retinal and eye research vol. (2021): 100971. doi: https://doi.org/10.1016/j.preteyeres.2021.100971
Brouwer NJ, Verdijk RM, Heegaard S, Marinkovic M, Esmaeli B, Jager MJ. Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options. Prog Retin Eye Res. 2021 May 17;100971. doi: 10.1016/j.preteyeres.2021.100971. Epub 2021 May 17. PMID: 34015548.
Copy Download .nbib Format: NLM
Native extracellular matrix, synthesized ex vivo by bone marrow or adipose stromal cells, faithfully directs mesenchymal stem cell differentiation.

Matrix biology plus

Marinkovic M, Tran ON, Block TJ, Rakian R, Gonzalez AO, Dean DD, Yeh CK, Chen XD.
PMID: 33543037
Matrix Biol Plus. 2020 Jun 24;8:100044. doi: 10.1016/j.mbplus.2020.100044. eCollection 2020 Nov.

Mesenchymal stem cells (MSCs) are highly responsive to cues in the microenvironment (niche) that must be recapitulated ex vivo to study their authentic behavior. In this study, we hypothesized that native bone marrow (BM)- and adipose (AD)-derived extracellular matrices...

Cite
Marinkovic M, Tran ON, Block TJ, et al. Native extracellular matrix, synthesized ex vivo by bone marrow or adipose stromal cells, faithfully directs mesenchymal stem cell differentiation. Matrix Biol Plus. 2020;8:100044doi: 10.1016/j.mbplus.2020.100044.
Marinkovic, M., Tran, O. N., Block, T. J., Rakian, R., Gonzalez, A. O., Dean, D. D., Yeh, C. K., & Chen, X. D. (2020). Native extracellular matrix, synthesized ex vivo by bone marrow or adipose stromal cells, faithfully directs mesenchymal stem cell differentiation. Matrix biology plus, 8100044. https://doi.org/10.1016/j.mbplus.2020.100044
Marinkovic, Milos, et al. "Native extracellular matrix, synthesized ex vivo by bone marrow or adipose stromal cells, faithfully directs mesenchymal stem cell differentiation." Matrix biology plus vol. 8 (2020): 100044. doi: https://doi.org/10.1016/j.mbplus.2020.100044
Marinkovic M, Tran ON, Block TJ, Rakian R, Gonzalez AO, Dean DD, Yeh CK, Chen XD. Native extracellular matrix, synthesized ex vivo by bone marrow or adipose stromal cells, faithfully directs mesenchymal stem cell differentiation. Matrix Biol Plus. 2020 Jun 24;8:100044. doi: 10.1016/j.mbplus.2020.100044. eCollection 2020 Nov. PMID: 33543037; PMCID: PMC7852316.
Copy Download .nbib Format: NLM
New technologies in the management of overactive bladder: current research and future prospects.

Therapeutic advances in urology

Marinkovic SP.
PMID: 31040883
Ther Adv Urol. 2019 Apr 25;11:1756287219844669. doi: 10.1177/1756287219844669. eCollection 2019.

Overactive bladder is characterized by frequency, urgency (wet or dry) and nocturia. These troublesome symptoms incur both a physiologic and economic cost, expected to be in excess of US$82 billion in the USA and Europe by the year 2020....

Cite
Marinkovic SP. New technologies in the management of overactive bladder: current research and future prospects. Ther Adv Urol. 2019;11:1756287219844669doi: 10.1177/1756287219844669.
Marinkovic, S. P. (2019). New technologies in the management of overactive bladder: current research and future prospects. Therapeutic advances in urology, 111756287219844669. https://doi.org/10.1177/1756287219844669
Marinkovic, Serge P. "New technologies in the management of overactive bladder: current research and future prospects." Therapeutic advances in urology vol. 11 (2019): 1756287219844669. doi: https://doi.org/10.1177/1756287219844669
Marinkovic SP. New technologies in the management of overactive bladder: current research and future prospects. Ther Adv Urol. 2019 Apr 25;11:1756287219844669. doi: 10.1177/1756287219844669. eCollection 2019. PMID: 31040883; PMCID: PMC6484233.
Copy Download .nbib Format: NLM
Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.

The British journal of ophthalmology

Jain P, Finger PT, Fili M, Damato B, Coupland SE, Heimann H, Kenawy N, J Brouwer N, Marinkovic M, Van Duinen SG, Caujolle JP, Maschi C, Seregard S, Pelayes D, Folgar M, Yousef YA, Krema H, Gallie B, Calle-Vasquez A.
PMID: 32892167
Br J Ophthalmol. 2021 Oct;105(10):1358-1364. doi: 10.1136/bjophthalmol-2020-316293. Epub 2020 Sep 05.

BACKGROUND: To relate conjunctival melanoma characteristics to local control.METHODS: Retrospective, registry-based interventional study with data gathered from 10 ophthalmic oncology centres from 9 countries on 4 continents. Conjunctival melanoma patients diagnosed between January 2001 and December 2013 were enrolled...

Cite
Jain P, Finger PT, Fili M, et al. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study. Br J Ophthalmol. 2020;105(10):1358-1364doi: 10.1136/bjophthalmol-2020-316293.
Jain, P., Finger, P. T., Fili, M., Damato, B., Coupland, S. E., Heimann, H., Kenawy, N., J Brouwer, N., Marinkovic, M., Van Duinen, S. G., Caujolle, J. P., Maschi, C., Seregard, S., Pelayes, D., Folgar, M., Yousef, Y. A., Krema, H., Gallie, B., Calle-Vasquez, A. (2021). Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study. The British journal of ophthalmology, 105(10), 1358-1364. https://doi.org/10.1136/bjophthalmol-2020-316293
Jain, Puneet, et al. "Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study." The British journal of ophthalmology vol. 105,10 (2021): 1358-1364. doi: https://doi.org/10.1136/bjophthalmol-2020-316293
Jain P, Finger PT, Fili M, Damato B, Coupland SE, Heimann H, Kenawy N, J Brouwer N, Marinkovic M, Van Duinen SG, Caujolle JP, Maschi C, Seregard S, Pelayes D, Folgar M, Yousef YA, Krema H, Gallie B, Calle-Vasquez A. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study. Br J Ophthalmol. 2021 Oct;105(10):1358-1364. doi: 10.1136/bjophthalmol-2020-316293. Epub 2020 Sep 05. PMID: 32892167; PMCID: PMC8479743.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 86 entries